DEBORAH DUNLAP: Open Payments
NPI 1699281535 · ASTORIA, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 12 payments from 5 companies in 2025. Trend: 2023 $560 · 2024 $659 · 2025 $598
Food & beverage: $555Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $411 |
| Novo Nordisk Inc | 1 | $118 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
Products named: BREZTRI, FARXIGA, Wegovy, ENHERTU, GVOKE HYPOPEN, Veozah, WATCHMAN FLX, AIRSUPRA.
Industry payments across OR — which companies pay providers there.
